Search Results - "Van Steeg, T.J."

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    Influence of plasma protein binding on pharmacodynamics: Estimation of in vivo receptor affinities of beta blockers using a new mechanism-based PK-PD modelling approach by van Steeg, T J, Boralli, V B, Krekels, E H J, Slijkerman, P, Freijer, J, Danhof, M, de Lange, E C M

    Published in Journal of pharmaceutical sciences (01-10-2009)
    “…The objective of this investigation was to examine in a systematic manner the influence of plasma protein binding on in vivo pharmacodynamics. Comparative…”
    Get more information
    Journal Article
  2. 2

    Effect of altered AGP plasma binding on heart rate changes by S(-)-propranolol in rats using mechanism-based estimations of in vivo receptor affinity (K(B,vivo)) by van Steeg, T J, Krekels, E H J, Freijer, J, Danhof, M, de Lange, E C M

    Published in Journal of pharmaceutical sciences (01-05-2010)
    “…In contrast to the impact of plasma protein binding on pharmacokinetics, no quantitative in vivo information is available on its impact on pharmacodynamics…”
    Get more information
    Journal Article
  3. 3

    Cutaneous side-effects of transdermal iontophoresis with and without surfactant pretreatment: a single-blinded, randomized controlled trial by Li, G.L., Van Steeg, T.J., Putter, H., Van Der Spek, J., Pavel, S., Danhof, M., Bouwstra, J.A.

    Published in British journal of dermatology (1951) (01-08-2005)
    “…Summary Background  Iontophoresis, a method that facilitates drug transport across skin by an external electrical field, offers the possibility for long‐term…”
    Get full text
    Journal Article
  4. 4

    Transdermal iontophoretic delivery of apomorphine in patients improved by surfactant formulation pretreatment by Li, G.L., de Vries, J.J., van Steeg, T.J., van den Bussche, H., Maas, H.J., Reeuwijk, H.J.E.M., Danhof, M., Bouwstra, J.A., van Laar, T.

    Published in Journal of controlled release (03-01-2005)
    “…The objective of the present study is to evaluate the efficacy and the safety of transdermal iontophoretic delivery of R-apomorphine, a potent dopamine…”
    Get full text
    Journal Article Conference Proceeding